Episode 6: A Conversation with Kevin Holden, Head of Synthetic Biology at Synthego Corporation
In episode #6 of GuidePost, Kevin Holden, Head of Synthetic Biology at Synthego Corporation, discusses the company's Silicon Valley culture, growth, and its approach to providing new gene editing products for the CRISPR community.
Episode 5: A Conversation with Neal Gutterson, CTO Corteva
In episode #5 of GuidePost Podcast Series Neal Gutterson, Chief Technology Officer of Dow-Dupont’s agricultural division Corteva, discusses the exciting potential of gene editing/CRISPR to spur new crop strains and circumvent the contentious debate around GMOs.
Episode 4: A Conversation with Jacob Sherkow of New York Law School
In episode #4 of GuidePost, Jacob Sherkow (New York Law School) – one of the leading academic authorities on biotech patent law – explains the twists and turns of the ongoing CRISPR patent dispute.
Episode 3: A conversation with Rodolphe Barrangou, Editor-in-Chief of The CRISPR Journal
The Editor-in-Chief of The CRISPR Journal, Rodolphe Barrangou (North Carolina State University), reflects on his decade on the frontlines of the CRISPR/gene editing revolution, and his ambitious plans for the new journal by and for the CRISPR community.
Listen to previous
episodes of GuidePost